UAE Intranasal Drug And Vaccine Delivery Market Size & Outlook

The intranasal drug and vaccine delivery market in the UAE is expected to reach a projected revenue of US$ 770.4 million by 2030. A compound annual growth rate of 4% is expected of the UAE intranasal drug and vaccine delivery market from 2024 to 2030.
Revenue, 2023 (US$M)
$587.2
Forecast, 2030 (US$M)
$770.4
CAGR, 2024 - 2030
4%
Report Coverage
UAE

UAE intranasal drug and vaccine delivery market, 2018-2030 (US$M)

UAE

Related Markets

UAE intranasal drug and vaccine delivery market highlights

  • The UAE intranasal drug and vaccine delivery market generated a revenue of USD 587.2 million in 2023 and is expected to reach USD 770.4 million by 2030.
  • The UAE market is expected to grow at a CAGR of 4% from 2024 to 2030.
  • In terms of segment, liquid delivery device was the largest revenue generating product in 2023.
  • Powder delivery device is the most lucrative product segment registering the fastest growth during the forecast period.


Intranasal drug and vaccine delivery market data book summary

Market revenue in 2023USD 587.2 million
Market revenue in 2030USD 770.4 million
Growth rate4% (CAGR from 2023 to 2030)
Largest segmentLiquid delivery device
Fastest growing segmentPowder delivery device
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationPowder delivery device, Liquid Delivery Device, Pressurized Metered Dose Inhaler
Key market players worldwideGSK PLC ADR, Teva Pharmaceutical Industries Ltd, AptarGroup Inc, UCB SA, Teleflex Inc, 3M Co, OptiNose Inc, Bespak, Intersect ENT


Other key industry trends

  • In terms of revenue, UAE accounted for 0.9% of the global intranasal drug and vaccine delivery market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Middle East & Africa, Saudi Arabia intranasal drug and vaccine delivery market is projected to lead the regional market in terms of revenue in 2030.
  • Saudi Arabia is the fastest growing regional market in Middle East & Africa and is projected to reach USD 1,114.7 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Intranasal Drug And Vaccine Delivery Market Companies

Name Profile # Employees HQ Website

UAE intranasal drug and vaccine delivery market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to intranasal drug and vaccine delivery market will help companies and investors design strategic landscapes.


Liquid delivery device was the largest segment with a revenue share of 43.09% in 2023. Horizon Databook has segmented the UAE intranasal drug and vaccine delivery market based on powder delivery device, liquid delivery device, pressurized metered dose inhaler covering the revenue growth of each sub-segment from 2018 to 2030.


The intranasal drug and vaccine delivery market in UAE holds considerable market value in the country. UAE has developed very rapidly from developing country with large nomadic population. This economic progress has brought opportunities and social benefits in the country.

Improvements in the performance of healthcare systems is among the key goals of the UAE national strategy. Key performance indicators include population health targets, such as reducing tobacco consumption & increasing life expectancy, along with structural and organizational targets, including regulatory requirements for all healthcare facilities to be externally accredited.

The launch of tracking system by mid-2020 in Dubai will enable the Dubai Health Authority to monitor and trace medicines, with an aim to improve patient safety. Thus, increasing number of approvals is expected to ensure availability of high-quality medical devices in UAE, thereby propelling market growth.

Reasons to subscribe to UAE intranasal drug and vaccine delivery market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of UAE intranasal drug and vaccine delivery market databook

  • Our clientele includes a mix of intranasal drug and vaccine delivery market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the UAE intranasal drug and vaccine delivery market , including forecasts for subscribers. This country databook contains high-level insights into UAE intranasal drug and vaccine delivery market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

UAE intranasal drug and vaccine delivery market size, by product, 2018-2030 (US$M)

UAE Intranasal Drug And Vaccine Delivery Market Outlook Share, 2023 & 2030 (US$M)

UAE intranasal drug and vaccine delivery market size, by product, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more